6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
US7919490B2 · kind B2 · utility
18Cited by
11References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2007 |
| Grant date | Apr 5, 2011 |
| Priority date | — |
| Expiry date | Apr 26, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel purinones and purines useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formulae I and II shown below, in which Q is selected from the group consisting of CX and nitrogen; and A is chosen from the group consisting of H, (C1-C6) alkyl, heteroaryl, and aryl:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.